Leukemia & Lymphoma, Volume 53, Issue 3 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 53, Issue 3 (2012)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Volume 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary on selected articles in this issue

Article Commentary
Fluorodeoxyglucose positron emission tomography/computed tomography for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy?
Michael S. Hofman
Pages: 349-351
Published online: 05 Dec 2011
First Page PreviewforFluorodeoxyglucose positron emission tomography/computed tomography for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy? | Full Text | References | PDF (136.9 KB) | Supplemental
  • 588 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Article Commentary
Quality of life after chemotherapy or hematopoietic cell transplant in follicular lymphoma: what's next?
Nicholas A. Barber & Fausto R. Loberiza Jr
Pages: 352-353
Published online: 03 Jan 2012
CitationforQuality of life after chemotherapy or hematopoietic cell transplant in follicular lymphoma: what's next? | Full Text | References | PDF (126.5 KB) | Supplemental
  • 598 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management
Eliza A. Hawkes, Andrew Wotherspoon & David Cunningham
Pages: 354-361
Published online: 19 Sep 2011
AbstractforThe unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management | Full Text | References | PDF (328.1 KB) | Supplemental
  • 807 Views
  • 13 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
Eric van den Neste, Rémi Letestu, Thérèse Aurran-Schleinitz, Loïc Ysebaert, Pierre Feugier, Stéphane Leprêtre & Caroline Dartigeas
Pages: 362-370
Published online: 19 Sep 2011
AbstractforPost-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand? | Full Text | References | PDF (202.8 KB) | Supplemental
  • 379 Views
  • 5 CrossRef citations
  • 0Altmetric
Review Article
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature
Kourosh Rezania, Betty Soliven, Joseph Baron, Helen Lin, Vikram Penumalli & Koen van Besien
Pages: 371-380
Published online: 29 Sep 2011
AbstractforMyasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature | Full Text | References | PDF (248.3 KB) | Supplemental
  • 934 Views
  • 20 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era
Simon E. Richardson, Jagoda Sudak, Victoria Warbey, Alan Ramsay & Christopher J. McNamara
Pages: 381-385
Published online: 24 Oct 2011
AbstractforRoutine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era | Full Text | References | PDF (169.2 KB) | Supplemental
  • 466 Views
  • 35 CrossRef citations
  • 0Altmetric

Research Article

Article
The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma
Silke Andresen, Juliane Brandt, Sascha Dietrich, Marie-Luise Memmer, Anthony D. Ho & Mathias Witzens-Harig
Pages: 386-393
Published online: 10 Oct 2011
AbstractforThe impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma | Full Text | References | PDF (358.9 KB) | Supplemental
  • 418 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Improved outcome for very elderly patients with diff use large B-cell lymphoma in the immunochemotherapy era
Sverker Hasselblom, Martin Stenson, Olle Werlenius, Monica Sender, Catharina Lewerin, Ulrika Hansson, Herman Nilsson-Ehle & Per-Ola Andersson
Pages: 394-399
Published online: 10 Oct 2011
AbstractforImproved outcome for very elderly patients with diff use large B-cell lymphoma in the immunochemotherapy era | Full Text | References | PDF (226.4 KB) | Supplemental
  • 499 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma
Xingchen Wu, Hannu Pertovaara, Pasi Korkola, Martine Vornanen, Hannu Eskola & Pirkko-Liisa Kellokumpu-Lehtinen
Pages: 400-405
Published online: 05 Dec 2011
AbstractforGlucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma | Full Text | References | PDF (366.5 KB) | Supplemental
  • 261 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
Role of glutathione-s-transferase (gst) polymorphisms in patients with advanced hodgkin lymphoma: results from the hd2000 GISL trial
Fortunato Morabito, Stefan Hohaus, Corrado Mammi, Luigi Marcheselli, Massimo Gentile, Francesco Merli, Antonella Montanini, Caterina Stelitano, Antonio La Sala, Renato Scalone, Maria Teresa Voso, Stefano Luminari, Emilio Iannitto, Paolo Gobbi & Massimo Federico
Pages: 406-410
Published online: 14 Sep 2011
AbstractforRole of glutathione-s-transferase (gst) polymorphisms in patients with advanced hodgkin lymphoma: results from the hd2000 GISL trial | Full Text | References | PDF (252.6 KB) | Supplemental
  • 324 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma
Manuela Giachelia, Maria Teresa Voso, Maria Chiara Tisi, Maurizio Martini, Valentina Bozzoli, Giuseppina Massini, Francesco D'Aló, Luigi Maria Larocca, Giuseppe Leone & Stefan Hohaus
Pages: 411-416
Published online: 24 Oct 2011
AbstractforInterleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma | Full Text | References | PDF (287.5 KB) | Supplemental
  • 369 Views
  • 33 CrossRef citations
  • 0Altmetric
Article
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia
Clemens-Martin Wendtner, Peter Hillmen, Daruka Mahadevan, Andreas Bühler, Lutz Uharek, Steven Coutré, Olga Frankfurt, Adrian Bloor, Francesc Bosch, Richard R. Furman, Eva Kimby, John G. Gribben, Marco Gobbi, Luke Dreisbach, David D. Hurd, Mikkael A. Sekeres, Alessandra Ferrajoli, Sheetal Shah, Jennie Zhang, Laure Moutouh-de Parseval, Michael Hallek, Nyla A. Heerema, Stephan Stilgenbauer & Asher A. Chanan-Khan
Pages: 417-423
Published online: 15 Nov 2011
AbstractforFinal results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia | Full Text | References | PDF (221.7 KB) | Supplemental
  • 942 Views
  • 49 CrossRef citations
  • 0Altmetric
Article
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
Giuseppe Gritti, Gianluigi Reda, Francesco Maura, Alfonso Piciocchi, Luca Baldini, Stefano Molica, Antonino Neri & Agostino Cortelezzi
Pages: 424-429
Published online: 05 Jan 2012
AbstractforLow dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia | Full Text | References | PDF (251 KB) | Supplemental
  • 384 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Low dose palliative radiotherapy for splenomegaly in hematologic disorders
Konstantin Lavrenkov, Sari Krepel-Volsky, Itai Levi & Samuel Ariad
Pages: 430-434
Published online: 23 Sep 2011
AbstractforLow dose palliative radiotherapy for splenomegaly in hematologic disorders | Full Text | References | PDF (163.6 KB) | Supplemental
  • 881 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia
David Claxton, Harry P. Erba, Stefan Faderl, Martha Arellano, Roger M. Lyons, Tibor Kovacsovics, Janice Gabrilove, Dirk Huebner, Pritesh J. Gandhi, Hagop Kantarjian & for the CLASSIC II Investigators
Pages: 435-440
Published online: 24 Oct 2011
AbstractforOutpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia | Full Text | References | PDF (197.1 KB) | Supplemental
  • 442 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms
Peter Johansson, Ruben Mesa, Robyn Scherber, Johanna Abelsson, Jan Samuelsson, Gunnar Birgegård & Björn Andréasson
Pages: 441-444
Published online: 24 Oct 2011
AbstractforAssociation between quality of life and clinical parameters in patients with myeloproliferative neoplasms | Full Text | References | PDF (159.8 KB) | Supplemental
  • 798 Views
  • 42 CrossRef citations
  • 0Altmetric
Article
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML)
Sarah M. Larson, Nicholas P. Campbell, Dezheng Huo, Andrew Artz, Yanming Zhang, Devika Gajria, Margaret Green, Howie Weiner, Christopher Daugherty, Olatoyosi Odenike, Lucy A. Godley, Elizabeth Hyjek, Sandeep Gurbuxani, Michael Thirman, Dorothy Sipkins, Koen van Besien, Richard A. Larson & Wendy Stock
Pages: 445-450
Published online: 13 Sep 2011
AbstractforHigh dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML) | Full Text | References | PDF (205.5 KB) | Supplemental
  • 1262 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array
Wu Yujie, Zhu Yu, Qian Sixuan, Wang Li, Liu Peng, Ge Zeng, Zhang Sujiang & Li Jianyong
Pages: 451-455
Published online: 28 Nov 2011
AbstractforDetection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array | Full Text | References | PDF (256.3 KB) | Supplemental
  • 289 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk
Takayoshi Tachibana, Masatsugu Tanaka, Ayumi Numata, Hirotaka Takasaki, Satomi Ito, Rika Ohshima, Maki Hagihara, Etsuko Yamazaki, Naoto Tomita, Katsumichi Fujimaki, Jun Taguchi, Rika Sakai, Hiroyuki Fujita, Shin Fujisawa, Atsuo Maruta, Yoshiaki Ishigatsubo & Heiwa Kanamori
Pages: 456-461
Published online: 24 Oct 2011
AbstractforPretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk | Full Text | References | PDF (301.3 KB) | Supplemental
  • 305 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines
Aparajita Chowdhury, Sanjib Chowdhury & Ming Ying Tsai
Pages: 462-471
Published online: 24 Oct 2011
AbstractforA novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines | Full Text | References | PDF (1.3 MB) | Supplemental
  • 496 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
A rapid and simple assay for human blood malignancy engraftment, homing and chemotherapy treatment using fluorescent imaging of avian embryos
Igor Grinberg, Anna Dukhovny & Ronald S. Goldstein
Pages: 472-478
Published online: 15 Nov 2011
AbstractforA rapid and simple assay for human blood malignancy engraftment, homing and chemotherapy treatment using fluorescent imaging of avian embryos | Full Text | References | PDF (452.1 KB) | Supplemental
  • 140 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Murine Schnurri-2 controls natural killer cell function and lymphoma development
Junji Yamashita, Chiaki Iwamura, Kunitoshi Mitsumori, Hiroyuki Hosokawa, Tetsuya Sasaki, Munehisa Takahashi, Hitoshi Tanaka, Kenji Kaneko, Asami Hanazawa, Yukiko Watanabe, Kenta Shinoda, Damon Tumes, Shinichiro Motohashi & Toshinori Nakayama
Pages: 479-486
Published online: 25 Nov 2011
AbstractforMurine Schnurri-2 controls natural killer cell function and lymphoma development | Full Text | References | PDF (570.7 KB) | Supplemental
  • 332 Views
  • 4 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Distinct clonal deletions of the long arm of chromosome 5 in a patient with myelodysplastic syndrome
Nathalie Douet-Guilbert, Etienne De Braekeleer, Audrey Basinko, Frédéric Morel, Marie-Josée Le Bris & Marc De Braekeleer
Pages: 487-489
Published online: 29 Sep 2011
First Page PreviewforDistinct clonal deletions of the long arm of chromosome 5 in a patient with myelodysplastic syndrome | Full Text | References | PDF (377 KB) | Supplemental
  • 112 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter

Letter
Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia
Jeffrey A. Jones, Eric H. Kraut, Deidre Deam, John C. Byrd & Michael R. Grever
Pages: 490-491
Published online: 13 Dec 2011
CitationforHematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia | Full Text | References | PDF (153.5 KB) | Supplemental
  • 191 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Thioredoxin-interacting protein and chronic lymphocytic leukemia
E. Friday, N. Koshy, V. Bhanderi & F. Turturro
Pages: 492-494
Published online: 15 Nov 2011
First Page PreviewforThioredoxin-interacting protein and chronic lymphocytic leukemia | Full Text | References | PDF (181.1 KB) | Supplemental
  • 197 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Mercaptopurine-induced hypersensitivity febrile reaction in patient with acute promyelocytic leukemia
Nikolaos Neokleous, Ourania Seimeni, Sotirios Koumas & Chrystalla Prokopiou
Pages: 495-496
Published online: 24 Oct 2011
CitationforMercaptopurine-induced hypersensitivity febrile reaction in patient with acute promyelocytic leukemia | Full Text | References | PDF (131.8 KB) | Supplemental
  • 81 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia
Laura Cannella, Giuseppina Loglisci, Mauro Nanni, Maria Rosaria de Cuia, Gioia Colafigli, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena & Massimo Breccia
Pages: 497-498
Published online: 29 Sep 2011
CitationforTrisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia | Full Text | References | PDF (135 KB) | Supplemental
  • 179 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results
Paolo Anderlini, Rima M. Saliba, Celina Ledesma, Christina Chancoco, Amin M. Alousi, Elizabeth J. Shpall, Uday R. Popat, Chitra M. Hosing, Issa F. Khouri, Yago Nieto, Stefan Ciurea, Anas Younes, Michelle A. Fanale, Sandra Acholonu, Rosamar Valverde & Richard E. Champlin
Pages: 499-502
Published online: 24 Oct 2011
First Page PreviewforGemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results | Full Text | References | PDF (170.5 KB) | Supplemental
  • 327 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study
Vladimir Lazarevic, Mats Remberger, Hans Hägglund, Gunnar Juliusson, Hamdy Omar, Helene Halböök, Eva Kimby, Claes Malm, Anders Wahlin & Jan-Erik Johansson
Pages: 503-505
Published online: 15 Nov 2011
First Page PreviewforLong-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study | Full Text | References | PDF (176.8 KB) | Supplemental
  • 196 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma
Kelley V. Foyil, Dana A. Kennedy, Laurie E. Grove, Nancy L. Bartlett & Amanda F. Cashen
Pages: 506-507
Published online: 10 Oct 2011
CitationforExtended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma | Full Text | References | PDF (227.5 KB) | Supplemental
  • 876 Views
  • 13 CrossRef citations
  • 0Altmetric
Letter
Genetic alterations in members of the Wnt pathway in acute leukemia
Yucel Erbilgin, Ozden Hatirnaz Ng, Nurhan Mavi, Ugur Ozbek & Muge Sayitoglu
Pages: 508-510
Published online: 24 Oct 2011
First Page PreviewforGenetic alterations in members of the Wnt pathway in acute leukemia | Full Text | References | PDF (178.4 KB) | Supplemental
  • 308 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography in symmetrically enlarged axillary and inguinal lymph nodes of Ofuji's papuloerythroderma
Soo Hyun Lee, Jin Seok Kim, Jae-Hoon Lee, Zhenlong Zheng & Sung Bin Cho
Pages: 511-513
Published online: 24 Oct 2011
First Page Previewfor18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography in symmetrically enlarged axillary and inguinal lymph nodes of Ofuji's papuloerythroderma | Full Text | References | PDF (249.3 KB) | Supplemental
  • 111 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma
Silvia Mangiacavalli, Giovanni Albani, Tommaso Caravita, Federica Cocito, Cristiana Pascutto, Patrizia Zappasodi, Sara Bringhen, Antonio Palumbo, Mario Cazzola & Alessandro Corso
Pages: 514-515
Published online: 05 Dec 2011
CitationforSimilar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma | Full Text | References | PDF (135.1 KB) | Supplemental
  • 274 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles